; Skip to content

Trial Objectives


Researchers want to understand how the body of a person with active lung cancer responds to COVID-19, should they contract the virus. Volunteers do not need to be vaccinated or to have an active case of COVID to participate. Study participants will be required to provide a blood sample and their medical history.

Who Can Participate


Adults with an active diagnosis of lung cancer.

Age: 18+ Gender Any

Estimated Time Commitment


Up to 24 months. In-person study visits occurring at enrollment and at these monthly intervals- 3, 6, 9, 12, 15, 18, 21 and 24 months.

Payment & Reimbursement


Payment Not Provided

Travel Reimbursement Not Available

Trial Contact


For more information, contact:

Daniell Plomondon
303-270-2041

Request More Information

Trial Location


National Jewish Main Campus, Denver, CO

Trial Sponsors


National Cancer Institute

Principal Investigators

Jeffrey Kern

Jeffrey Kern, MD

Co-Investigators

  • Laurie L. Carr

    Laurie L. Carr, MD

  • Ellen Volker

    Ellen Volker, MD, MSPH

Request more Information

By completing this form, you agree to learn more about this study and see if you qualify.

I would also like to receive periodic emails with health information, news and clinical research updates from National Jewish Health required